The 1 for 5 distribution matches what I estimated, but with today's prices, this would reduce the AMPE price by about $0.66 (one-fifth AYTU price). Hopefully the AYTU settles at its price by Dec 1 and doesn't drop after distribution.
this says it all.... Here's what I sent to my Broker:- Please set a reminder to inform me when the AYTU shares through the Ampio dividend arrive in my account.
Record Date: Only Ampio stockholders of record on December 1, 2015 will be entitled to receive the Aytu shares. Particularly for those stockholders who hold their Ampio stock in "street name" through their broker, the Company recommends that stockholders contact their broker to confirm they are holders of Ampio stock and that they expect one (1) Aytu share of common stock for every five (5) Ampio shares of common stock they own and request to be alerted when the Aytu shares are received in their accounts.
I know you are a lying #$%$ short tout. Now you have again proved your stupidity.
How many shares will Macaluso own? Based on his reported ownership of Ampio and the roughly 1 share of AYTU for each 5 shares of Ampio the AYTU distribution will provide for every Ampio shareholder , Macaluso will own approximately 500,000 shares of AYTU.
Not exactly 0 you jerkweed.
Yup, he said that enrollment is going slower than previous AMPE trials, due to more stringent criteria, in order maximize the chance of success of the upcoming trial, just no slower than expected.
That is in accordance with all previous AMPE trials. It has to be proceeding slower than usual, even with the added observation period, because of more stringent enrollment criteria and competing OAK clinical trials.
I spoke with Gregory Gould on Friday, he stated that the recruitment is going as planned and that they will release a PR statement shortly after the final shot, though he did not give an exact date.
The fact that ACT and Knoll appear to still be invested is good. Both ACT and Knoll have a good reputation in biotech. But, they invest knowing the risk of failure, which they can afford.
The other significant holders (more than 1%) appear to be passive or index-related. Their changes are much less meaningful.
thank you for your reply. I always enjoy reading a fact filled rebuttal. allow me to summarize your case "this is awesome, trust me, because I know a lot."
I'll ask you two questions: how many shares of AYTU will AMPE own post spin? How many AYTU shares will MM own after the spin?
if the answer is zero, then please reconcile why MM, who is one greedy guy and if anything, is focused like a laser on enriching himself, would give away such value?
Update from WhaleWisdom.
Susqeuhanna Intl Group sold about 40% of their position last Q. They still own 0.6%.
Blackrock Inst Trust was *changed* from selling all to still holding 2.3%.
New 13Fs for significant holders:
Blackrock Inst Trust 2.3% Sold 117K shares
Susquenhanna 0.6% Sold 238K shares (AMPE ranks 5917th top holding)
Geode Cap Mgmt 0.4% New holding
They don't need to. Most bio tech's use that a positive sign. But these guys are so dead quiet one can't help but think there's a big announcement coming.
I usually dont respond to such ignorance and lack of knowledge but you obviously need to get back into the school books son. You have to understand the strategy these small cap biotechs take and what your seeing is very strategic. Please have something of value you either way vs. waisting your time OUT
Can you quantify soon? Is it possible we hear about the final patient injection at the same time we hear about the sale of optina and the dividend you mention? Next week would be nice.